Literature DB >> 17541170

Antimicrobial activity of oleanolic acid from Salvia officinalis and related compounds on vancomycin-resistant enterococci (VRE).

Kumiko Horiuchi1, Sumiko Shiota, Tsutomu Hatano, Takashi Yoshida, Teruo Kuroda, Tomofusa Tsuchiya.   

Abstract

An extract from Salvia officinalis (Sage) leaves showed antimicrobial activity against vancomycin-resistant enterococci (VRE). We isolated the effective compound and identified it as oleanolic acid, a triterpenoid. We also tested antimicrobial activity of similar triterpenoids, ursolic acid, uvaol, betulinic acid and betulin. We found that ursolic acid also showed antimicrobial activity against VRE. The minimum inhibitory concentrations (MICs) of oleanolic acid and ursolic acid were 8 and 4 microg/ml, respectively. These two compounds also showed antimicrobial activity against Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus (MRSA). These compounds showed bactericidal activity against VRE at least for 48 h when added at concentrations that were two-times higher than their MICs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541170     DOI: 10.1248/bpb.30.1147

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  36 in total

1.  Oleanolic and ursolic acids influence affect the expression of the cysteine regulon and the stress response in Escherichia coli.

Authors:  Anna M Grudniak; Anna Kurek; Jolanta Szarlak; Krystyna I Wolska
Journal:  Curr Microbiol       Date:  2011-01-09       Impact factor: 2.188

2.  Biotransformation using Mucor rouxii for the production of oleanolic acid derivatives and their antimicrobial activity against oral pathogens.

Authors:  Clarissa S Capel; Ana C D de Souza; Tatiane C de Carvalho; João P B de Sousa; Sérgio R Ambrósio; Carlos H G Martins; Wilson R Cunha; Rosario H Galán; Niege A J C Furtado
Journal:  J Ind Microbiol Biotechnol       Date:  2011-01-13       Impact factor: 3.346

Review 3.  The Genus Alternanthera: Phytochemical and Ethnopharmacological Perspectives.

Authors:  Rajeev K Singla; Vivek Dhir; Reecha Madaan; Deepak Kumar; Simranjit Singh Bola; Monika Bansal; Suresh Kumar; Ankit Kumar Dubey; Shailja Singla; Bairong Shen
Journal:  Front Pharmacol       Date:  2022-04-11       Impact factor: 5.988

4.  Antimicrobial Mechanism of Oleanolic and Ursolic Acids on Streptococcus mutans UA159.

Authors:  Soon-Nang Park; Yun Kyong Lim; Mi-Hwa Choi; Eugene Cho; Iel Soo Bang; Jung Min Kim; Sug-Joon Ahn; Joong-Ki Kook
Journal:  Curr Microbiol       Date:  2017-08-29       Impact factor: 2.188

5.  Apoptotic and anti-angiogenic effects of Salvia triloba extract in prostate cancer cell lines.

Authors:  Harika Atmaca; Emir Bozkurt
Journal:  Tumour Biol       Date:  2015-10-12

6.  Antimicrobial and antibiofilm effects of abietic acid on cariogenic Streptococcus mutans.

Authors:  Yuki Ito; Takashi Ito; Keisuke Yamashiro; Fumi Mineshiba; Kimito Hirai; Kazuhiro Omori; Tadashi Yamamoto; Shogo Takashiba
Journal:  Odontology       Date:  2019-09-13       Impact factor: 2.634

7.  3-Oxo-18α-olean-28,13β-olide.

Authors:  R C Santos; R M A Pinto; A Matos Beja; J A R Salvador; J A Paixão
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-31

8.  Oleanolic acid and ursolic acid inhibit peptidoglycan biosynthesis in Streptococcus mutans UA159.

Authors:  Soon-Nang Park; Sug-Joon Ahn; Joong-Ki Kook
Journal:  Braz J Microbiol       Date:  2015-06-01       Impact factor: 2.476

9.  Structural and bioactive studies of terpenes and cyclopeptides from the Genus Rubia.

Authors:  Kuo Xu; Penglong Wang; Bin Yuan; Yatao Cheng; Qiang Li; Haimin Lei
Journal:  Chem Cent J       Date:  2013-05-04       Impact factor: 4.215

10.  Antimicrobial and antioxidant activities of Cortex Magnoliae Officinalis and some other medicinal plants commonly used in South-East Asia.

Authors:  Lai Wah Chan; Emily L C Cheah; Constance L L Saw; Wanyu Weng; Paul W S Heng
Journal:  Chin Med       Date:  2008-11-28       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.